Peritoneal Dialysis News Archive
Hemodialysis patients had higher rates of infective endocarditis than peritoneal dialysis and kidney transplant patients.
Except for gabapentin, evidence for 38 other treatments is weak and limited by small studies with a high risk of bias, new review finds.
VTE is more common among dialysis patients than in the general population, and the risk is highest in the first 6 months after dialysis initiation.
ESRD patients aged 60-64 years with no insurance or who are on Medicaid are less likely to initiate peritoneal dialysis.
Gentamicin cream use was associated with fewer exit-site infections due to gram-negative bacteria.
New and established peritoneal dialysis patients both showed this trend.
Their risk of the rare but life-threatening condition is twice as high as in hemodialysis patients.
Hypo- and hyperthyroidism predict an increased risk of all-cause mortality.
Assisted peritoneal dialysis and in-center hemodialysis are associated with similar hospitalization rates.
Sodium levels below 140 mEq/L associated with a higher death risk vs levels of 140 to less than 142 mEq/L.
Researchers found a 16% lower risk for strokes, heart attacks, and death combined among patients who took ACEIs or ARBs.
The risk is most elevated among individuals aged 44 years or younger.
New findings implicate transferrin saturation and nutritional status assessed by albumin.
Researchers report successful use of catheters within 24 hours in urgent situations.
Trend started around the introduction of the Medicare prospective payment system for dialysis care.
Blacks undergoing PD or home HD and Hispanics undergoing PD are less likely than their white counterparts to receive a kidney transplant.
Study of peritoneal dialysis patients showed that they do not adjust binders to match the phosphate content of meals and snacks.
Meta-analysis suggests a 9% decreased 5-year mortality risk associated with pre-transplant peritoneal dialysis versus hemodialysis.
Daily home hemodialysis also decreases likelihood of hospitalization and technique failure.
Cutting back on dietary phosphorus in addition to taking phosphate binders achieved greater decreases in serum phosphate in PD patients.
In a study, home hemodialysis was associated with a 53% decreased risk of death compared with peritoneal dialysis.
New report shows that Montenegro had the lowest rate of renal replacement therapy.
Starting on peritoneal dialysis was associated with a 25% lower dementia risk versus starting on hemodialysis, a study showed.
Mission 0by25 hopes to stop preventable deaths from AKI by 2025.
Risk of hospitalization and modality failure is significantly lower, Canadian study finds.
Study of coronary artery calcification (CAC) risk also shows serum phosphorus levels associated with nutritional intake and dialysis adequacy.
New study excluded hemodialysis patients who used central venous catheters for vascular access.
Experts say that issues of cost to providers have prevented broader application of home dialysis.
Large study looked at matched pairs of lupus patients with renal disease starting dialysis with hemodialysis or peritoneal dialysis.
Highest survival rates found among patients whose initial dialysis modality was PD but where then switched to hemodialysis.
Hemodialysis patients are at higher risk than peritoneal dialysis and renal transplant recipients.
The risk is more than 13 times greater than with peritoneal dialysis.
Study reveals a decline in the use of erythropoiesis-stimulating agents and an increase in the use of iron.
The adjusted rate fell 26.5% from 1996 to 2011, but remains much higher than in the general population.
Folic acid treatment significantly improved hemoglobin levels and decreased epoetin alfa use.
Researchers speculate patients on peritoneal dialysis are more physically active than those on HD, and this may lower diabetes risk.
Vascular calcification contributes to increased cardiovascular risk in dialysis patients.
Study of patients new to dialysis also demonstrates an increase in the likelihood of hospitalization.
No difference in time to peritoneal-dialysis-related infection with honey at exit site, usual care
PD may lower glutamate levels released into the brain during ischemic stroke, minimizing tissue damage
Severe fluid overload in patients with advanced CKD increases by threefold the likelihood of initiation of renal replacement therapy.
Boosting PD use in the U.S. to 12% of dialysis patients from the current 7% would save about $300 million a year, researcher says.
New findings confirm the prognostic value of serum creatinine levels as a surrogate of muscle mass.
Peritoneal dialysis patients can undergo the procedure on an outpatient basis.
Patients on peritoneal dialysis (PD) who experience an exit-site infection (ESI) are at increased risk for peritonitis.
The condition was found in nearly 32% of hemodialysis patients, compared with only 8% and 5% of peritoneal dialysis and kidney transplant patients.
Hemodialysis and peritoneal dialysis patient experience similar amelioration in glomerular filtration rate decline.
They may differ from hemodialysis patients with respect to case mix, volume status, disease management, and routine exposure to anticoagulation.
Oral sodium bicarbonate may ease hyperphosphatemia in peritoneal dialysis (PD) patients with metabolic acidosis.
Patients initiating dialysis have a lower hospitalization risk in the first year if they start on peritoneal dialysis (PD) instead of hemodialysis (HD).
The risk is three times greater when compared with hemodialysis.
Risk of peritonitis elevated six-fold in 30 days before death in patients on treatment
ST. JOHN'S, NEWFOUNDLAND—Patients on peritoneal dialysis (PD) are at 51% higher risk of being hospitalized for infections than those receiving hemodialysis (HD), according to findings presented at the Canadian Society of Nephrology annual meeting.
Many patients start dialysis treatment with hemodialysis (HD) even though they initially had opted for peritoneal dialysis (PD), according to researchers.
PRAGUE—For patients with congestive heart failure (CHF) who initiate maintenance dialysis, those starting on peritoneal dialysis (PD) have a significantly greater death risk than those starting on hemodialysis (HD), according to a French study.
PRAGUE—End-stage renal disease patients who start on peritoneal dialysis (PD) rather than hemodialysis (HD) spend less time on a renal transplant waiting list before getting a kidney, new findings suggest.
Hemodialysis (HD) vascular access type at the time of dialysis initiation may be an important modifier that can affect overall patient survival, according to a new Canadian study.
PHOENIX—Lower serum magnesium levels are a significant predictor of mortality in patient on peritoneal dialysis (PD), researchers found.
PHOENIX—Marked hyperglycemia in diabetic patients on chronic peritoneal dialysis (CPD) are at increased risk of death, a study found.
Fungal peritonitis has a worse prognosis than bacterial peritonitis in patients on peritoneal dialysis (PD), according to a study. It is associated with higher rates of catheter removal, technique failure, and mortality.
New findings suggest that iron may have a role in the pathogenesis of calciphylaxis.
A study of risk factors associated with peritoneal dialysis (PD) catheter survival found that a non-infectious catheter-related problem was the only independent variable significantly associated with an increased risk of catheter failure.
A survey of 1,621 U.S. dialysis patients shows that although peritoneal dialysis (PD) had been discussed with 61% of those individuals, only 10.9% of the informed patients chose this dialysis method.
Patients with end-stage renal disease (ESRD) who convert to hemodialysis (HD) after failing treatment with peritoneal dialysis (PD) may be at higher death risk in the first year than ESRD patients who used HD as their primary treatment, but researchers caution that the association may not be causal.
Reasons include a lack of nephrologist training in the modality and a number of mistaken beliefs.
Compared with incident hemodialysis (HD) patients, incident peritoneal dialysis (PD) patients, especially non-diabetics, show a robust and consistent survival advantage for up to five years.
Central venous catheters are the most prevalent access type in patients who initiated hemodialysis (HD) following a failed renal transplant.
Home-based peritoneal dialysis may be less intrusive in their lives than in-center hemodialysis.
SEATTLE—A study by British investigators suggests that more older patients with end-stage renal disease (ESRD) should be educated about peritoneal dialysis (PD) and the potential benefits it may offer over hemodialysis (HD).
In an eight-week study of 15 patients, oral niacinamide added to standard phosphorus-lowering therapies resulted in a modest yet significant reduction in plasma phosphorus levels in patients on peritoneal dialysis.
SAN DIEGO—Following renal transplant failure, patients starting peritoneal dialysis (PD) have better survival in the first year than patients starting on hemodialysis (HD), but the survival advantage lessens with time, British resesarchers reported at the American Society of Nephrology's Renal Week conference.
The use of peritoneal dialysis (PD) is increasing at a faster rate in developing than in developed countries, according to what Canadian researchers say is the first comprehensive assessment of PD worldwide.
A Canadian study of 4,247 patients on peritoneal dialysis (PD) found that older age, black race, switching to PD from hemodialysis (HD), and diabetes in women were associated with a significantly increased risk of peritonitis.
Patients transferred from hemodialysis (HD) to peritoneal dialysis (PD) because of complications do not have a greater risk of death than patients who started renal replacement therapy on PD, Polish researchers reported in Nephrology Dialysis Transplantation (2009; published online ahead of print).
Hypokalemia in patients on continuous ambulatory peritoneal dialysis (CAPD) may be a risk factor for peritonitis and poor nutritional status, data show.
Patients transferred from hemodialysis (HD) to peritoneal dialysis (PD) because of complications do not have a greater risk of death than patients who started renal replacement therapy on PD.
Peritoneal dialysis (PD) patients treated with ACE inhibitors or angiotensin receptor blockers (ARBs) have a 62% reduced risk of death compared with PD patients not treated with these medications, after adjusting for age, BP, and other variables, according to a report in Nephrology Dialysis Transplantation (2008; published online ahead of print).
LONDON, Ont.—Patients on peritoneal dialysis (PD) live longer than those on hemodialysis (HD), at least during the first years after dialysis starts, a new study suggests. A question remains, however, whether it is the type of dialysis that makes the difference in survival.
STOCKHOLM—Vitamin D deficiency increases the risk of death and cardiovascular problems in patients with renal disease, according to studies presented here at the European Renal Association-European Dialysis and Transplant Association 2008 congress.
STOCKHOLM—Contrary to prevailing belief, patients on peritoneal dialysis (PD) have a higher phosphorus burden than do patients on hemodialysis (HD).
STOCKHOLM—Most hemodialysis and peritoneal dialysis patients have aortic calcification (AC) around the time they start dialysis, according to researchers.
STOCKHOLM—Obesity is a strong risk factor for the decline in residual renal function (RRF) after patients start dialysis, researchers in The Netherlands say.
STOCKHOLM—Although hemodialysis (HD) is the most common form of renal replacement therapy, 53% of nephrologists worldwide believe patients whose dialysis is planned should start on peritoneal dialysis, according to a survey conducted by Gambro.
ORLANDO—Patients with gram-negative peritonitis (GNP) undergoing early catheter removal have a higher rate of permanent transfer to hemodialysis but a lower death rate compared with GNP patients not having their catheter removed, according to study findings presented here at the 2008 Annual Dialysis Conference.
DaVita Inc., has launched DaVita Diet Helper to make kidney-friendly meals easy to plan, prepare, and track.
SAN DIEGO—A catheter-chewing cockatoo may have led clinicians to a new tool for the treatment of peritoneal dialysis (PD)-related zygomycete peritonitis.
BARCELONA—Pro-inflammatory cytokines are a marker for increased cardiovascular and overall mortality in dialysis patients, new research demonstrates.
Pentraxin 3, a mediator of inflammation, is markedly elevated in patients on hemodialysis (HD) but not in patients on peritoneal dialysis (PD) or in patients with chronic renal failure (CRF) not on dialysis, according to researchers.
Serum levels of fetuin-A predictor of all-cause, cardiovascular, and non-cardiovascular mortality in dialysis patients, a Dutch study found.
Patients who initiate renal replacement therapy on peritoneal dialysis (PD) are about 50% less likely to die within 90 days than those who start on hemodialysis (HD), a study found.
Higher levels of C-reactive protein (CRP) are independently associated with adverse outcomes in peritonitis associated with peritoneal dialysis (PD), according to Canadian researchers.
DENVER—Gentamicin cream applied daily to the catheter exit site in patients on peritoneal dialysis (PD) reduces the rate of catheter infection, according to findings presented here at the Annual Dialysis Conference.
Outcomes among pediatric peritoneal dialysis (PD) patients differ by gender and race, according to a study.
Researchers report a dramatic increase in the number of patients in their 80s and 90s starting dialysis.
Body composition tends to change significantly during the first year of dialysis, but the changes depend on which type of dialysis is administered.
Widely accepted guidelines for managing bone metabolism and disease in CKD patients are valid for the peritoneal dialysis (PD) population, Dutch researchers conclude.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)